Nevertheless, we identified CLDN18 overexpression as an independent factor of poor prognosis for HCC, which provides new insights into the pathological mechanism of HCC progression, especially in the context of tumor immune environment. Here, CLDN18 is linked to hepatocellular carcinoma.